FineMark National Bank & Trust’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-800
Closed -$28K 800
2016
Q4
$28K Hold
800
﹤0.01% 751
2016
Q3
$28K Hold
800
﹤0.01% 740
2016
Q2
$30K Hold
800
﹤0.01% 738
2016
Q1
$32K Hold
800
﹤0.01% 692
2015
Q4
$29K Sell
800
-25
-3% -$904 ﹤0.01% 738
2015
Q3
$26K Buy
825
+25
+3% +$851 ﹤0.01% 792
2015
Q2
$27K Hold
800
﹤0.01% 816
2015
Q1
$27K Hold
800
﹤0.01% 814
2014
Q4
$28K Hold
800
﹤0.01% 828
2014
Q3
$26K Hold
800
﹤0.01% 819
2014
Q2
$27K Hold
800
﹤0.01% 816
2014
Q1
$28K Hold
800
0.01% 785
2013
Q4
$29K Buy
800
+300
+60% +$11K 0.01% 721
2013
Q3
$17K Hold
500
﹤0.01% 848
2013
Q2
$17K Buy
+500
New +$16.6K 0.01% 841

Other funds holding ACH

FineMark National Bank & Trust's ACH Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of Accendra Health (ACH) in Q1 2017, closing a stake of 800 shares — an estimated $28K sold.

FineMark National Bank & Trust first reported a position in ACH in Q2 2013 and held it in 15 quarters. The position peaked at $32K in Q1 2016. 284 funds tracked by Wall St. Rank hold ACH as of Q1 2017.

  • FineMark National Bank & Trust reported no remaining Accendra Health position as of Q1 2017 after selling out during the quarter.
  • FineMark National Bank & Trust sold 800 Accendra Health shares in Q1 2017, an estimated $28K.
  • FineMark National Bank & Trust first reported a position in Accendra Health in Q2 2013 and held it in 15 quarters.
  • FineMark National Bank & Trust's Accendra Health position peaked at $32K in Q1 2016.
  • 284 funds tracked by Wall St. Rank held Accendra Health as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.